We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $615M invested in Meridian Bioscience Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

657% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $281K

41% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 49

14% more capital invested

Capital invested by funds: $541M → $615M (+$74.1M)

5% less funds holding

Funds holding: 186 → 177 (-9)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
69
Reduced
49
Closed
22
Calls
$2.13M
Puts
$281K
Net Calls
+$1.85M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.74M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.29M
4
SBH
Segall Bryant & Hamill
Illinois
+$3.16M
5
Invesco
Invesco
Georgia
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$5.9M
2
BCM
Brown Capital Management
Maryland
-$5.14M
3
Rafferty Asset Management
Rafferty Asset Management
New York
-$4.43M
4
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$3.25M
5
Prudential Financial
Prudential Financial
New Jersey
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
POIA
176
Pin Oak Investment Advisors
Texas
$1K +$984 +66 New
Rafferty Asset Management
177
Rafferty Asset Management
New York
– -$4.43M -311,884 Closed
JG
178
Jefferies Group
New York
– -$601K -42,329 Closed
SLA
179
Silver Lake Advisory
Utah
– -$517K -36,376 Closed
HCM
180
Hollencrest Capital Management
California
– -$503K -35,400 Closed
MSL
181
Mackay Shields LLC
New York
– -$446K -31,400 Closed
ARTA
182
A.R.T. Advisors
New York
– -$417K -29,400 Closed
FQ
183
First Quadrant
California
– -$338K -23,808 Closed
HCM
184
Highbridge Capital Management
New York
– -$323K -22,723 Closed
SCM
185
Stevens Capital Management
Pennsylvania
– -$303K -21,332 Closed
II
186
Ibex Investors
Colorado
– -$294K -20,715 Closed
CCIA
187
Campbell & Co Investment Adviser
Maryland
– -$222K -15,620 Closed
CI
188
Cigna Investments
Connecticut
– -$208K -14,611 Closed
Acadian Asset Management
189
Acadian Asset Management
Massachusetts
– -$201K -14,147 Closed
CSS
190
Cubist Systematic Strategies
Connecticut
– -$187K -13,163 Closed
Commonwealth Equity Services
191
Commonwealth Equity Services
Massachusetts
– -$181K -12,812 Closed
KI
192
Koch Industries
Kansas
– -$178K -12,529 Closed
Nomura Holdings
193
Nomura Holdings
Japan
– -$175 -12,268 Closed
AP
194
Advisors Preferred
Maryland
– -$65K -4,603 Closed
Ohio Public Employees Retirement System (OPERS)
195
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$42K -2,932 Closed
Loomis, Sayles & Company
196
Loomis, Sayles & Company
Massachusetts
– -$20K -1,419 Closed
TWA
197
TCI Wealth Advisors
Arizona
– -$3K -177 Closed
4 5 6 7
8

VIVO Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2018, worth a combined $615M — up 14% from $541M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VIVO and 16 opened new positions — a net loss of 6 holders — while 49 trimmed existing stakes and 69 added.

The largest buyer was BlackRock, adding an estimated $7.74M. The largest seller was Millennium Management, cutting an estimated $5.9M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2018, down from 186 in Q1 2018.
  • Funds reported $615M of Meridian Bioscience Inc stock for Q2 2018, up 14% quarter-over-quarter.
  • 16 funds opened new Meridian Bioscience Inc positions in Q2 2018 and 22 closed out, a net change of -6 holders.
  • The largest Meridian Bioscience Inc buyer in Q2 2018 was BlackRock, an estimated $7.74M added.
  • The largest Meridian Bioscience Inc seller in Q2 2018 was Millennium Management, an estimated $5.9M sold.

Based on aggregated 13F filings for Q2 2018.